Financial Performance - Sales revenue for the year ended December 31, 2025, increased by 73% to $1,310.1 million from $756.6 million in 2024[3]. - Net profit for the year ended December 31, 2025, rose significantly to $472.3 million, compared to $65.3 million in 2024, marking a growth of 624%[3]. - Basic earnings per share for 2025 reached 117.80 cents, up from 15.82 cents in 2024[3]. - Operating cash flow for the year ended December 31, 2025, was $710.0 million, an increase from $306.9 million in 2024[3]. - Total revenue increased by 73% from $756.6 million in 2024 to $1,310.1 million in 2025[17]. - Operating income rose from $123 million in 2024 to $590 million in 2025, marking a significant increase[16]. - Net profit surged to $472.3 million in 2025, compared to $65.3 million in 2024, an increase of 407%[17]. - Mining operating profit for the year ended December 31, 2025, was $684.0 million, an increase of $497.1 million from $186.9 million in 2024[36]. - The company reported a total comprehensive income of $583,772 thousand for 2025, compared to $58,147 thousand in 2024, a significant increase of 901%[120]. Production and Operations - Total gold production for the three months ended December 31, 2025, decreased by 21% to 47,875 ounces from 60,406 ounces in the same period of 2024[14]. - Total copper production for the three months ended December 31, 2025, was 37.0 million pounds, down from 44.1 million pounds in 2024[14]. - Gold production increased by 9% from 162,652 ounces in 2024 to 177,225 ounces in 2025[17]. - Copper production saw a 48% rise from 105.7 million pounds in 2024 to 156.3 million pounds in 2025[17]. - The company processed 2,871,882 tons of ore in Q4 2025, a decrease of 7.3% from 3,095,471 tons in Q4 2024, while the annual processing increased by 44.5% to 11,838,916 tons from 8,197,448 tons[59]. - The average copper grade was 0.69% in Q4 2025, down from 0.78% in Q4 2024, while the copper recovery rate improved to 85% from 82%[59]. Cash and Liquidity - Cash and cash equivalents as of December 31, 2025, amounted to $399.4 million, compared to $183.8 million in 2024[3]. - The company reported a net cash increase of $209,471 thousand in 2025, compared to $85,850 thousand in 2024, which is an increase of 144%[128]. - The company’s cash balance as of December 31, 2025, was $739.4 million, including cash and cash equivalents of $399.4 million and restricted cash of $34.2 million[68]. - The company generated a net cash inflow from operating activities of $710.0 million for the year ended December 31, 2025, primarily driven by a pre-tax profit of $560.2 million[75]. Research and Development - Research and development expenses for Q4 2025 were $16.4 million, up from $8.1 million in Q4 2024, reflecting increased focus on recovery and optimization processes[30]. - Research and development expenses increased to $32.8 million in 2025 from $15.7 million in 2024, focusing on improving recovery rates and optimizing mining processes[36]. Capital Expenditure and Investments - Capital expenditure on property, plant, and equipment for the year ended December 31, 2025, was $50.1 million, slightly up from $48.3 million in 2024[3]. - The company has capital commitments related to the acquisition of equipment and machinery for two mining areas, with total repayment commitments of $504.985 million for bank loans[84]. - The net cash outflow from investing activities was $246.8 million, mainly used for fixed deposits and property, plant, and equipment purchases[76]. Debt and Financing - The total debt of the company as of December 31, 2025, was $533.4 million, resulting in a debt-to-equity ratio of 0.23, down from 0.26 as of September 30, 2025[79]. - The company has secured a loan agreement with a syndicate of banks for a total principal amount of RMB 2.1 billion (approximately $294 million), with an interest rate of 1.5%[70]. - The company has a remaining loan balance of RMB 1.39 billion (approximately $197 million) with an annual interest rate of 1.5%, maturing on November 5, 2028[69]. Inventory and Assets - The company's inventory as of December 31, 2025, is approximately $295 million, with in-process gold inventory accounting for about $249 million, representing approximately 7.4% of total assets[106]. - The total assets increased to $3,356,535 thousand in 2025, up from $2,935,979 thousand in 2024, showing a growth of 14%[122]. - The total liabilities increased to $464,019 thousand in 2025 from $341,046 thousand in 2024, reflecting a growth of 36%[122]. Dividend and Shareholder Returns - The company plans to distribute a basic dividend of $0.47 per share for the year ending December 31, 2025, totaling $186.8 million, which includes a basic dividend of $140.1 million and a special dividend of $46.7 million[96]. - The company has established a new optimized dividend policy, which includes a basic dividend and a variable portion based on financial performance and market conditions[95]. Compliance and Governance - The internal controls over financial reporting were assessed as effective as of December 31, 2025, providing reasonable assurance regarding the timely recording and reporting of financial information[99]. - The independent auditor's report confirmed that the consolidated financial statements present a true and fair view of the group's financial position as of December 31, 2025[103]. - The company is responsible for preparing the financial statements in accordance with International Financial Reporting Standards and ensuring that they are free from material misstatement due to fraud or error[112]. Risk Factors - The company must ensure compliance with various risk factors, including metal price fluctuations, government regulations, and operational risks in China, which could adversely affect its business and financial performance[100]. - The company has not taken measures to hedge against foreign exchange risks but is monitoring these risks[82].

Financial Performance - The total revenue for the year ended December 31, 2025, was HKD 777,252,000, representing a 24.2% increase from HKD 625,830,000 in 2024[3] - The gross profit for the same period was HKD 129,341,000, slightly up from HKD 127,437,000 in the previous year, indicating a stable gross margin[3] - The net loss attributable to the company’s shareholders for 2025 was HKD 257,345,000, a reduction from a loss of HKD 300,275,000 in 2024, showing an improvement of approximately 14.3%[4] - The company reported a total comprehensive loss of HKD 251,348,000 for 2025, compared to HKD 330,136,000 in 2024, reflecting a decrease of about 24%[5] - The company reported a pre-tax loss of HKD 269,002,000 in 2025, an improvement from a loss of HKD 312,083,000 in 2024[23] - The basic loss per share attributable to the company's owners for 2025 was HKD (257,345,000), compared to HKD (300,275,000) in 2024, indicating a reduction in losses[37] Assets and Liabilities - The total assets less current liabilities amounted to HKD 540,566,000, down from HKD 724,384,000 in 2024, indicating a decline of approximately 25.4%[6] - The company’s total liabilities rose to HKD 605,120,000 in 2025, compared to HKD 341,927,000 in 2024, representing an increase of approximately 77%[6] - The company’s equity attributable to shareholders decreased to HKD 268,615,000 from HKD 502,922,000, a decline of about 46.7%[6] - The total assets of the company rose to HKD 1,145,686,000 in 2025, compared to HKD 1,066,311,000 in 2024, reflecting an increase of about 7.4%[24] - The total liabilities increased significantly to HKD 967,456,000 in 2025 from HKD 644,301,000 in 2024, marking an increase of approximately 50.2%[24] Revenue Segments - Revenue from visual effects and post-production services amounted to HKD 605,893,000, up from HKD 518,242,000, representing a growth of 16.9%[16] - Revenue from virtual human services increased significantly to HKD 73,227,000 from HKD 22,813,000, marking a growth of 220.5%[16] - Revenue from e-sports products surged to HKD 91,050,000 from HKD 4,938,000, indicating a growth of 1,743.5%[16] - The total revenue from the trading segment, which includes semiconductor memory chips and e-sports products, was HKD 98,132,000, compared to HKD 84,775,000 in the previous year[17] - The media and entertainment segment generated revenue of approximately HKD 679,120,000, an increase from HKD 541,055,000 in 2024, but incurred a loss of HKD 123,928,000[70] Expenses and Costs - The company incurred financial costs of HKD 35,545,000, which is an increase from HKD 29,781,000 in the previous year, reflecting a rise of approximately 19.2%[3] - The company’s administrative expenses decreased significantly to HKD 286,950,000 from HKD 390,422,000, showing a reduction of about 26.5%[3] - The cost of sales and services for 2025 was HKD 647,911,000, an increase of 30% from HKD 498,393,000 in 2024[33] - Total employee costs for 2025 amounted to HKD 550,245,000, up 13.5% from HKD 484,773,000 in 2024[33] Cash Flow and Financing - Cash and cash equivalents increased to HKD 426,369,000 from HKD 400,120,000, marking a growth of about 6.5%[6] - The group held unused bank financing of HKD 48,143,000 as of December 31, 2025, which is expected to support liquidity needs[14] - The group is in the process of renewing bank financing arrangements, which are expected to be completed smoothly based on its credit history[14] - The group had a total of 172,902,762 stock options available for grant under the 2022 stock option plan as of January 1, 2025[141] - As of December 31, 2025, the total cash and bank balance was approximately HKD 426,369,000[148] Impairment and Goodwill - The total impairment loss for the year was HKD 36,035,000, reflecting ongoing challenges in asset valuation[41] - The carrying amount of goodwill as of December 31, 2025, was HKD 213,611,000, down from HKD 249,912,000 in 2024[40] - The goodwill allocated to the visual effects production cash-generating unit is approximately HKD 209,206,000, with a recoverable amount of about HKD 323,087,000, reflecting an average growth rate of 10.2% over a five-year budget period[133] - The goodwill for the post-production cash-generating unit is approximately HKD 40,440,000, with no recoverable amount this year, resulting in a goodwill impairment loss of HKD 36,035,000[134] Strategic Initiatives and Future Outlook - The group plans to implement comprehensive policies to monitor cash flow through cost-cutting and capital expenditure reductions[14] - The company plans to enhance its visual effects business by integrating AI-driven production techniques and optimizing its product portfolio[153] - The group will adopt a prudent operational approach, including cost reduction and potential restructuring to improve overall performance[153] - The company is actively pursuing collaborations in the virtual human domain, including a partnership with Toppan Printing Co., Ltd. to utilize high-resolution data from biometric scans[101] Legal and Compliance - In a legal dispute, the company was ordered to pay $250,638 in compensatory damages and $345,098 in profit restitution related to a specific film[87] - The company has successfully resolved several lawsuits, leading to the dismissal of claims against its clients in other related cases[89] - The company is pursuing insurance compensation for claims related to ongoing litigation, with discussions ongoing regarding defense costs for its clients[89] Awards and Recognition - Digital Domain received multiple nominations at the 2025 Australian Effects & Animation Festival, including for the films "Captain America: Brave New World" and "Minecraft: The Movie"[73] - The company was nominated for Best Visual Effects at the 2025 Filmfare Awards for its work on "Fear Street 2"[74] - Digital Domain was recognized as the 7th most innovative company in North America by Fast Company for its advanced production technology, particularly the Masquerade3 technology used in "Fantastic Four: Hero's First Step"[78] Employee and Corporate Governance - The group has a total of 864 employees, with a competitive salary policy and performance-based promotions[151] - The company held only two regular board meetings during the year instead of the required four, but the board believes sufficient meetings were held to understand the group's business operations and development[158] - The chairman and CEO roles were consolidated under Mr. Wang, who was appointed as both on January 13, 2025, following Mr. Xie's resignation[158] Market Conditions - The macroeconomic environment remains challenging, with geopolitical tensions and inflation pressures impacting operational costs and consumer sentiment[152] - The company is actively seeking steady growth strategies in a challenging global business environment[125]

Financial Performance - Revenue for the year ended December 31, 2025, reached RMB 61,182,689 thousand, representing a 9.5% increase from RMB 55,863,577 thousand in 2024[3] - Gross profit increased by 23.5% to RMB 11,196,071 thousand, compared to RMB 9,063,729 thousand in the previous year[3] - Net profit rose by 21.8% to RMB 1,615,546 thousand, up from RMB 1,326,282 thousand in 2024[3] - Profit attributable to equity shareholders increased by 39.1% to RMB 1,335,820 thousand, compared to RMB 960,470 thousand in 2024[3] - Basic earnings per share from continuing operations increased by 37.7% to RMB 1.01, up from RMB 0.68 in the previous year[3] - The board proposed a cash dividend of RMB 1.8 per 10 shares for shareholders[3] - The total revenue for 2025 reached RMB 61,182,689,000, an increase of 9.4% from RMB 55,863,577,000 in 2024[18] - Total financial expenses amounted to RMB 1,074,680 thousand in 2025, compared to RMB 827,840 thousand in 2024, reflecting an increase of 29.8%[25] - Employee costs totaled RMB 12,555,672 thousand in 2025, an increase of 9.1% from RMB 10,596,537 thousand in 2024[25] - The company reported a pre-tax profit of RMB 2,185,222 thousand for 2025, representing a 9.5% increase from RMB 1,995,749 thousand in 2024[27] Assets and Liabilities - Total assets as of December 31, 2025, amounted to RMB 68,154,537 thousand, compared to RMB 64,165,868 thousand in 2024[9] - Total liabilities increased to RMB 44,127,677 thousand, up from RMB 44,320,325 thousand in 2024[9] - Net assets increased to RMB 24,026,860 thousand, compared to RMB 19,845,543 thousand in the previous year[10] - Trade receivables and notes receivable amounted to RMB 9,902,298,000, compared to RMB 9,510,515,000 in 2024, indicating an increase of 4.1%[18] - Total loans and borrowings increased significantly to RMB 15,821,651 thousand in 2025, compared to RMB 8,495,857 thousand in 2024, reflecting an increase of approximately 86.5%[34] Research and Development - Research and development expenses increased to RMB 3,288,978 thousand, a rise of 27.3% from RMB 2,584,929 thousand in 2024[4] - The company plans to enhance its product competitiveness by increasing R&D resources and focusing on new technologies and products to adapt to rapid technological changes in the automotive sector[76] - R&D expenses rose from RMB 2,584.9 million in 2024 to RMB 3,289.0 million in 2025, an increase of RMB 704.0 million or 27.2%, driven by investments in autonomous driving and emerging smart technologies[90] Market and Sales - Revenue from automotive parts sales was RMB 58,164,845,000, up from RMB 53,320,665,000, reflecting a growth of 9.3%[18] - Revenue from China was RMB 16,736,384 thousand in 2025, up 18.2% from RMB 14,156,943 thousand in 2024, while overseas revenue increased by 6.6% to RMB 44,446,305 thousand[24] - The company secured new full lifecycle orders amounting to approximately RMB 97 billion, with the automotive safety business accounting for about RMB 50.9 billion and the automotive electronics business for about RMB 46.1 billion[45] Operational Efficiency - The company is implementing multiple measures to improve operational efficiency and reduce impairment risks related to goodwill from acquisitions, especially in light of potential adverse economic changes[77] - The company plans to optimize its global supply chain and production efficiency by increasing the self-supply ratio of core components and enhancing production capacity utilization[67] Strategic Initiatives - The company is focusing on high-speed charging and power conversion technologies, with core products achieving global mass production and addressing the demand for ultra-fast charging solutions[55] - The company aims to establish a comprehensive intelligent networking ecosystem by integrating various product forms and leveraging its regulatory experience in global markets[54] - The company is actively pursuing new strategies for market expansion and product development in the autonomous driving sector[121] Compliance and Governance - The company has complied with all applicable provisions of the Corporate Governance Code during the reporting period[116] - The audit committee, composed of independent non-executive directors, has reviewed the accounting principles and practices without objection[114] - The company's auditor, KPMG, confirmed that the financial data disclosed in the annual performance announcement aligns with the audited consolidated financial statements[115] Future Outlook - The company aims to achieve rapid growth in revenue and profit by 2026, although this goal is subject to external environmental changes and industry developments[71] - The company is closely monitoring macroeconomic trends and industry risks to adjust its operational strategies and maintain flexibility in production and supply chain planning[72]

Financial Performance - For the fiscal year ending December 31, 2025, GigaDevice Semiconductor Inc. reported a revenue of RMB 9.203 billion, representing a year-on-year growth of 25.12%[12] - The net profit attributable to shareholders for the same period was RMB 1.648 billion, reflecting a significant increase of 49.47% year-on-year[12] - The company reported a revenue of RMB 9,203,463 thousand for the year ending December 31, 2025, representing a 25.1% increase from RMB 7,355,978 thousand in 2024[53] - Gross profit margin improved to 39.1% in 2025 from 35.7% in 2024, with gross profit reaching RMB 3,601,971 thousand[53] - Adjusted net profit (non-IFRS measure) for 2025 was RMB 1,815,176 thousand, up from RMB 1,259,915 thousand in 2024, resulting in an adjusted net profit margin of 19.7%[55] - Annual profit increased from RMB 1,100.9 million for the year ending December 31, 2024, to RMB 1,677.3 million for the year ending December 31, 2025, representing a growth of approximately 52.3%[91] Revenue Breakdown - The revenue from the storage chip business grew by 26.41% year-on-year, with notable performance in the Flash business line, particularly in consumer and automotive markets[13] - The MCU business line achieved a revenue growth of 12.98% year-on-year, despite a competitive industry landscape, through strategic planning and enhanced R&D efficiency[13] - Dedicated storage chip revenue rose to RMB 6,565.9 million in 2025, with sales volume increasing by 24.8% to 4,435.9 million units[60] - MCU revenue grew by 13.0% to RMB 1,909.9 million, with sales volume increasing by 22.3% to 500.3 million units[62] - Analog chip revenue surged from RMB 15.5 million in 2024 to RMB 332.8 million in 2025, with sales volume increasing significantly to 2,137.6 million units[64] Market Position and Strategy - The global semiconductor market size reached USD 772 billion in 2025, with a year-on-year growth of 22%[16] - The global MCU market is projected to reach USD 21 billion in 2025, with the company holding a leading position in the 32-bit MCU segment[18] - The global market for specialized storage, including NOR Flash and SLC NAND Flash, is expected to reach USD 15.7 billion in 2025[17] - The company holds an 18.5% market share in the global NOR Flash market, ranking second overall and first among mainland Chinese companies[133] - The company aims to enhance its market share in NOR Flash products, focusing on automotive, computing, edge AI, and overseas markets, while continuing to benefit from the reduction and exit of major players in the DRAM sector[144] Research and Development - The company invested approximately RMB 3.73 billion in R&D over the past three years, with a goal of enhancing AI-enabled product innovation[14] - The company will invest approximately RMB 3.727 billion in R&D from 2023 to 2025, with 1,533 R&D staff making up 65.71% of total employees[42] - The company plans to continuously improve R&D efficiency and transform R&D results effectively, while also focusing on industry customer engagement and building an industry ecosystem[147] - The company is committed to continuous technological innovation and expanding its product matrix to capture emerging market opportunities[138] Corporate Governance - The company is committed to maintaining high standards of corporate governance and transparency to enhance long-term shareholder returns[149] - The board of directors is responsible for the company's governance policies and compliance, ensuring adherence to corporate governance codes and regular reviews of governance practices[152] - The company has adopted a board diversity policy, emphasizing the importance of diverse perspectives in maintaining competitive advantage[158] - The company has established a robust risk management and internal control system to identify potential events that may affect its operations[188] Financial Position and Cash Flow - Cash and cash equivalents as of December 31, 2025, were RMB 9,161.9 million, compared to RMB 9,104.2 million as of December 31, 2024, indicating a slight increase of 0.6%[92] - Current assets increased from RMB 12,434.8 million as of December 31, 2024, to RMB 13,425.2 million as of December 31, 2025, a growth of approximately 8%[94] - Operating cash flow for the year ending December 31, 2025, was RMB 2,128.5 million, compared to RMB 2,032.2 million for the previous year, reflecting a growth of about 4.7%[99] - Cash used in investing activities for the year ending December 31, 2025, was RMB 1,390.6 million, up from RMB 669.3 million in 2024, indicating a significant increase of approximately 107.5%[100] Future Outlook - The global semiconductor market is projected to reach $975.5 billion by 2026, with a year-on-year growth of 26.3%, driven by the explosive demand for AI computing power[143] - The company plans to strengthen its international development strategy to enhance local service capabilities and overall operational capacity[141] - The company will advance its global strategy by strengthening its marketing and service network, particularly through the establishment of an international headquarters in Singapore to expand sales in Southeast Asia, Japan, the Americas, and Europe[148] Employee and Board Diversity - The company’s employee gender diversity is balanced, with females representing 35.41% and males 64.59%[161] - The board consists of 3 female directors and 6 male directors, with ages ranging from 32 to 68, ensuring a diverse knowledge and skill set[160]

Financial Performance - For the year ending December 31, 2025, the group's revenue was approximately RMB 47,084,000, an increase of about 123.05% compared to RMB 21,109,000 for the year ending December 31, 2024[3] - The group reported a loss of approximately RMB 59,990,000 for the year ending December 31, 2025, compared to a loss of RMB 34,646,000 for the year ending December 31, 2024[3] - The loss per share for the year ending December 31, 2025, was RMB 15.36, compared to RMB 8.87 for the year ending December 31, 2024[3] - The group's gross profit for the year ending December 31, 2025, was RMB 16,703,000, up from RMB 6,571,000 in the previous year[4] - Total comprehensive expenses for the year amounted to RMB 37,749,000, including a loss of RMB 34,645,000[13] - The company reported a net loss of approximately RMB 59,990,000 for the year ending December 31, 2025[13] - The company reported a loss attributable to owners from continuing operations of RMB 59,972,000 for 2025, compared to a loss of RMB 34,645,000 in 2024[36] - The company's discontinued operations reported a net loss of RMB 13,320,000 in 2025, compared to a profit of RMB 14,536,000 in 2024[53] Assets and Liabilities - Total assets as of December 31, 2025, were RMB 320,520,000, a decrease from RMB 327,749,000 as of December 31, 2024[6] - The group's net asset value decreased to RMB 63,284,000 as of December 31, 2025, from RMB 123,052,000 in the previous year[7] - The group had cash and cash equivalents of RMB 39,325,000 as of December 31, 2025, down from RMB 48,484,000 as of December 31, 2024[6] - The company’s total equity as of December 31, 2025, was RMB 63,284,000, reflecting a decrease from the previous year[13] - The company’s current liabilities exceeded its current assets by approximately RMB 158,906,000 as of December 31, 2025, raising significant doubts about its ability to continue as a going concern[13] - Total liabilities related to assets classified as held for sale amounted to RMB 77,839,000, indicating a substantial financial obligation[32] Revenue Sources - Revenue from pipeline natural gas sales increased to RMB 40,128,000 in 2025, up from RMB 21,109,000 in 2024, representing a growth of 90.1%[20] - Total revenue for 2025 reached RMB 47,084,000, compared to RMB 21,109,000 in 2024, marking a significant increase of 123.5%[20] - Other income rose to RMB 2,860,000 in 2025 from RMB 2,605,000 in 2024, reflecting an increase of 9.8%[21] - Major customers contributed significantly to revenue, with Customer A generating RMB 11,965,000 in 2025, while Customer B contributed RMB 9,224,000, up from RMB 8,112,000 in 2024[26] Expenses - The group incurred administrative and other expenses of RMB 41,651,000 for the year ending December 31, 2025, compared to RMB 27,054,000 in the previous year[4] - The total employee cost for 2025 was RMB 19,749,000, up from RMB 15,627,000 in 2024, indicating a rise of 26.9%[27] - Administrative expenses increased from RMB 27,054,000 in 2024 to RMB 41,651,000 in 2025, mainly due to the establishment of a new subsidiary in Hong Kong and increased employee costs[55] Dividends and Shareholder Information - The group did not recommend the payment of a final dividend for the year ending December 31, 2025[3] - The company did not declare or propose any dividends for 2025, consistent with the previous year[44] - As of December 31, 2025, Mr. Wang Zhongsheng holds 288,661,440 shares, representing 73.93% of the company's equity[69] - Ms. Zhao Xin, as the spouse of Mr. Wang Zhongsheng, holds 290,926,252 shares, equating to 74.51% of the company's equity[73] Legal and Compliance Matters - The company has ongoing litigation with a claim amounting to approximately RMB 22,311,000 related to unpaid exploration costs[45] - The company has made a solemn and irrevocable commitment to cover potential losses related to a specific litigation, with the belief that it will not significantly impact the financial condition and daily operations[84] - The company has complied with all applicable provisions of the Corporate Governance Code as of the publication date, except for the non-fixed term of independent non-executive directors[91] - All independent non-executive directors have confirmed their independence in accordance with GEM Listing Rules, and the company believes they are all independent individuals[94] Future Outlook and Strategic Initiatives - The company anticipates generating positive cash flow from operations in the foreseeable future[15] - The company has implemented measures to improve its liquidity and financial position, relying on continued financial support from its ultimate controlling party[14] - The company is focusing on the development of a new technology for natural gas production, aiming for a reaction environment of 800℃ to 950℃[65] - The company has signed a technical service agreement with a well-known local university to evaluate the advanced nature, economic viability, and sustainability of its new technology[65] Asset Sales and Disposals - The company completed the sale of its 100% equity in Shanxi Qinshi Shuntai Energy Development Co., Ltd. for approximately RMB 24,609,000 on February 3, 2026[15] - The company plans to sell its subsidiary Shanxi Qingshui Shuntai Energy Development Co., which operates its liquefied coalbed methane business, within the next twelve months[28] - The transfer registration of the sale of equity to relevant Chinese authorities has been completed[68] - The sale constitutes a very significant disposal as it exceeds 75% of the applicable percentage ratio, requiring shareholder approval, which was obtained on January 16, 2026[68] Financial Reporting and Standards - The company’s financial statements are prepared in accordance with Hong Kong Financial Reporting Standards, reflecting its operations primarily in China[12] - The company expects that the application of the new Hong Kong Financial Reporting Standard No. 18 will not have a significant impact on its financial performance and position[18]

Financial Performance - Revenue decreased from RMB 113 million for the year ending December 31, 2024, to RMB 74 million for the year ending December 31, 2025, primarily due to a reduction in CDMO services[4]. - Other income decreased from RMB 235 million for the year ending December 31, 2024, to RMB 152 million for the year ending December 31, 2025, mainly due to a decrease in interest income recognized[4]. - The company reported a net loss of RMB 203,725,000 for 2025, compared to a net loss of RMB 290,292,000 in 2024, an improvement of 29.8%[101]. - The total assets as of December 31, 2025, were RMB 924,833,000, down from RMB 1,200,277,000 in 2024[86]. - The total liabilities decreased to RMB 306,740,000 in 2025 from RMB 448,641,000 in 2024[86]. - The company's equity decreased to RMB 618,093,000 in 2025 from RMB 751,636,000 in 2024, a decline of 17.7%[103]. - The company reported a net cash outflow from operations of RMB 136 million for the year ending December 31, 2025, raising significant doubts about its ability to continue as a going concern[154]. Research and Development - R&D expenses decreased from RMB 192.1 million for the year ending December 31, 2024, to RMB 140.8 million for the year ending December 31, 2025, attributed to pipeline advancement and resource prioritization adjustments[6]. - The company is advancing its early-stage next-generation oncology product pipeline, including TST003, TST105, TST013, TST198, and ozekibart, with positive preclinical data for TST105 presented at the AACR annual meeting[10]. - TST106, a bispecific ADC candidate targeting CLDN18.2, is progressing towards IND submission with promising preclinical data[14]. - TST198, a novel RDC-targeting Claudin18.2 candidate, has shown ideal drug targeting and promising anti-tumor activity in preclinical studies[15]. - TST105, a bispecific ADC candidate targeting FGFR2b, demonstrated significantly enhanced anti-tumor activity in preclinical models compared to standard ADCs[18]. - TST003, a first-in-class humanized monoclonal antibody targeting GREMLIN-1, is currently being explored in solid tumors including colorectal cancer (CRC) and castration-resistant prostate cancer (CRPC)[37]. Clinical Trials and Progress - The company achieved significant late-stage clinical progress with the targeted Claudin18.2 antibody drug osemitamab (TST001) for treating Claudin18.2 expressing locally advanced or metastatic gastric or gastroesophageal junction cancer[8]. - Osemitamab (TST001) has shown promising results in a Phase II trial for advanced gastric/gastroesophageal junction cancer, with a median overall survival (mOS) of 21.7 months and a confirmed objective response rate (cORR) of 68%[16]. - The FDA has confirmed that bone mineral density (BMD) is a validated surrogate endpoint to support clinical trials for therapies treating postmenopausal osteoporosis, potentially accelerating the approval process for new therapies[11]. - Osemitamab (TST001) has received regulatory approvals from the FDA, China's NMPA, and Korea's MFDS to initiate global Phase III clinical trials for advanced gastric and gastroesophageal junction adenocarcinoma[26]. - The company is in discussions with multiple global and regional pharmaceutical companies regarding the development and commercialization of osemitamab (TST001)[9]. Financial Strategy and Funding - The company aims to secure at least USD 100 million in financing within the fiscal year to support strategic plans and operational development[72]. - The company plans to enhance its HiCB continuity technology platform and cell culture media products to attract industry partners for technology licensing and collaboration[84]. - The company is actively pursuing partnerships and funding for other pipeline projects, including TST003, TST013, TST198, blosozumab, TST801, TST808, and ozekibart, with progress in potential global or regional licensing arrangements[144]. - A strategic partnership and non-exclusive licensing agreement has been established with EirGenix Inc. for the HiCB platform, which includes upfront payments and potential milestone payments, as well as future royalties from commercialization[146]. Operational Efficiency and Cost Management - The company is implementing measures to streamline its organizational structure and prioritize investments in projects with the highest collaboration and commercial potential, resulting in significant cost savings and improved operational efficiency[151]. - The company aims to improve operational efficiency, reduce costs, enhance quality, and expand new capabilities to increase competitiveness[84]. - The company is maintaining constructive dialogues with major suppliers to extend payment terms, enhancing short-term cash flow flexibility while ensuring uninterrupted operations[149]. Market and Business Development - The company is expanding its service offerings in siRNA drug development and increasing its exposure in international markets[27]. - The company is expanding its CDMO business by acquiring new domestic clients and is in the final negotiation stages with several new clients, reflecting increased market recognition of its comprehensive development and production capabilities[150]. - The company has established clinical trial collaborations with BMS for osemitamab (TST001) and with Eli Lilly for blosozumab (TST002) in Greater China[59][61]. Shareholder and Corporate Governance - The board has proposed not to declare a final dividend for the year ended December 31, 2025[177]. - The audit committee has reviewed the consolidated financial statements for the year ended December 31, 2025, ensuring compliance with accounting standards and proper disclosures[174]. - The annual performance announcement is published on the Hong Kong Stock Exchange website and the company's website[178].

Financial Performance - Revenue increased by RMB 247.0 million or 4.1% to RMB 6,308.4 million for the year ending December 31, 2025[2] - EBITDA rose by RMB 279.0 million or 12.7% to RMB 2,470.7 million for the same period[2] - Gross profit increased by RMB 118.4 million or 2.9% to RMB 4,162.6 million, with a gross margin of 66.0%[2] - Profit before tax increased by RMB 105.4 million or 12.6% to RMB 944.6 million[2] - Net profit attributable to shareholders was RMB 618.7 million, an increase of RMB 146.8 million compared to the previous year[2] - Earnings per share rose to RMB 15.88 from RMB 12.54 in the previous year[2] - Total comprehensive income for the year was RMB 767.3 million, up from RMB 657.1 million[4] - The company reported a foreign exchange gain of RMB 51.2 million related to the translation of foreign operations[4] - Other comprehensive income for the year included a net amount of RMB 61.6 million after tax[4] Assets and Liabilities - Non-current assets totaled RMB 16,304,093 thousand in 2024, compared to RMB 17,592,647 thousand in 2025, reflecting a decrease of approximately 7.3%[5] - Current assets amounted to RMB 13,308,107 thousand in 2024, decreasing to RMB 15,232,692 thousand in 2025, indicating a growth of about 14.5%[6] - Total liabilities increased from RMB 10,769,142 thousand in 2024 to RMB 9,935,810 thousand in 2025, showing a decrease of approximately 8.2%[6] - The net asset value was RMB 2,538,965 thousand in 2024, rising to RMB 5,296,882 thousand in 2025, representing an increase of around 108.5%[6] - Total equity rose from RMB 15,753,670 thousand in 2024 to RMB 18,359,054 thousand in 2025, reflecting an increase of approximately 16.3%[6] - Non-current liabilities totaled RMB 3,089,388 thousand in 2024, increasing to RMB 4,530,475 thousand in 2025, indicating a growth of about 46.5%[6] Revenue Breakdown - Total revenue for the year ended December 31, 2024, reached RMB 6,308,374,000, with significant contributions from cardiovascular and digestive system drugs[16] - The sales of products amounted to RMB 5,662,856,000, with cardiovascular drugs generating RMB 1,958,356,000 and digestive system drugs RMB 1,152,355,000[16] - The geographical breakdown of revenue shows that mainland China and Asia (excluding mainland China) accounted for a significant portion of total sales[19] - Total revenue for the period reached RMB 6,061,441 thousand, with significant contributions from cardiovascular drugs (RMB 2,084,631 thousand) and oncology drugs (RMB 1,660,005 thousand)[21] Research and Development - The company has over 30 domestic and more than 10 international products in the research pipeline, focusing on innovative drug delivery technologies[60] - The company continues to invest in four strategic therapeutic areas: oncology, central nervous system, cardiovascular, and metabolism[86] - As of December 31, 2025, the R&D team consists of 590 employees, including 53 PhDs and 294 Master's degree holders, with a total of 251 patents granted in China and 577 patents granted overseas[85] Product Approvals and Innovations - The drug "Lepus" is the only marketed paclitaxel lipid formulation globally, recognized for its efficacy and safety[65] - "Beyouno" received approval for multiple cancer treatments and is included in the National Medical Insurance Drug List[66] - "Zanbiga" has been approved for the treatment of extensive-stage small cell lung cancer and is recommended in major clinical guidelines[68] - The company has launched the new drug Ruxinlin (Taurine Dihydrochloride Sustained Release Tablets) in China, which is the first domestically developed Class 1 chemical drug for treating depression with significant improvements in anxiety and cognitive abilities[73] Financial Costs and Taxation - Financial costs for 2025 are projected at RMB 561,785 thousand, a decrease from RMB 686,595 thousand in 2024, with bank and other loan interest at RMB 474,726 thousand[33] - The group reported a tax expense of RMB 194,211 thousand for 2025, compared to RMB 238,978 thousand in 2024, reflecting a decrease in tax liabilities[36] - The effective tax rate for the group in 2025 is 25.3%, up from 23.1% in 2024, indicating an increase in the overall tax burden[37] Corporate Governance and Future Plans - The group adheres to high standards of corporate governance, having adopted the corporate governance code effective July 1, 2025[146] - The group plans to invest significantly in expanding production capacity under the "Misbach Project 2027," with the first major milestone achieved by launching a new packaging production line that will double technical capacity[119] - The group is optimizing its pipeline structure and investing in innovative drug candidates to enhance long-term market competitiveness and international influence[123]

Financial Performance - Revenue for the year ended December 31, 2025, was RMB 783.1 million, an increase of 9.4% compared to RMB 715.9 million for the previous year[2] - Gross profit for the same period was RMB 50.6 million, representing a 4.3% increase from RMB 48.5 million in the prior year[2] - The company recorded a net loss of RMB 30.6 million for the year, an improvement from a net loss of RMB 54.8 million in the previous year[2] - The company reported a loss before tax of RMB 30.1 million, compared to a loss of RMB 54.5 million in the previous year[4] - The company reported a total comprehensive loss of RMB 37,909,000 in 2025, compared to a loss of RMB 32,394,000 in 2024, indicating a year-over-year increase in losses of approximately 16%[5] - The company's basic loss per share was RMB 4.40 in 2025, an improvement from RMB 5.05 in 2024, reflecting a reduction in losses per share[5] - The group reported a net loss of approximately RMB 30,552,000 for the year ending December 31, 2025[12] - The group reported a net loss of RMB 30.6 million this year, despite total revenue rising to RMB 783.1 million from RMB 715.9 million last year[44] Revenue Breakdown - Total revenue for the group in 2025 was RMB 783,092,000, compared to RMB 715,740,000 in 2024, reflecting an overall growth of about 9.4%[24] - Revenue from travel-related products and services, including total revenue from free travel product sales, travel group sales, and travel package sales, amounted to RMB 780.9 million, accounting for 99.7% of total revenue[49] - Revenue from travel group sales was RMB 382,520,000 in 2025, up from RMB 289,075,000 in 2024, marking an increase of approximately 32.3%[25] - Revenue from self-service products sales totaled RMB 386,205,000 in 2025, down from RMB 397,529,000 in 2024, indicating a decrease of about 2.7%[25] - Revenue from external customers in mainland China reached RMB 781,735,000 in 2025, an increase from RMB 698,113,000 in 2024, representing a growth of approximately 11.9%[21] - Revenue from external customers in Hong Kong was RMB 1,357,000 in 2025, a significant decrease from RMB 17,755,000 in 2024, indicating a decline of approximately 92.3%[21] Expenses and Costs - Selling and distribution expenses increased to RMB 32.1 million from RMB 28.3 million in the previous year[4] - Administrative expenses decreased to RMB 27.0 million from RMB 39.8 million year-on-year[4] - The cost of sales rose by 9.8% to RMB 732.5 million from RMB 667.4 million, attributed to the recovery of the travel industry[60] - The group's gross profit for the current year was RMB 50.6 million, compared to RMB 48.5 million last year, with a gross profit margin of 6.5%[61] - Financial costs for 2025 include bank loans and other interest expenses totaling RMB 8,421,000, while 2024 was RMB 9,143,000, indicating a decrease of approximately 7.9%[26] - Total interest expenses for 2025 amounted to RMB 8,769,000, compared to RMB 9,949,000 in 2024, showing a decline of approximately 11.8%[26] Assets and Liabilities - Total assets decreased from RMB 408,006,000 in 2024 to RMB 337,437,000 in 2025, representing a decline of about 17.3%[6] - The company's total liabilities increased from RMB 350,525,000 in 2024 to RMB 408,709,000 in 2025, marking an increase of approximately 16.6%[6] - The company’s total equity attributable to shareholders decreased from RMB 58,636,000 in 2024 to RMB 44,469,000 in 2025, a decrease of about 24.1%[7] - The company reported a net current liability of RMB (703,000) in 2025, an improvement from RMB (13,088,000) in 2024, indicating a reduction in net liabilities[6] - The group’s current liabilities reached approximately RMB 703,000 as of December 31, 2025[116] Market Outlook and Strategy - The company plans to continue focusing on expanding its travel-related services in response to market recovery[2] - Future outlook remains cautious but optimistic, with expectations of further revenue growth as tourism continues to rebound[2] - The management team believes the group is well-positioned to capitalize on opportunities and enhance competitive advantages in the coming years[48] - The company aims to leverage the recovery in the tourism sector to enhance its market position and expand its service offerings[50] - The group anticipates benefiting from the increasing flow of cross-border tourism and the growing global demand for Chinese cultural tourism experiences[47] Governance and Compliance - The company has maintained compliance with corporate governance standards, with the board of directors committed to enhancing governance practices[107] - The audit committee consists of three independent non-executive directors, ensuring a wealth of business experience in financial and legal matters[110] - The independent auditor's report confirmed that the consolidated financial statements reflect the group's financial position as of December 31, 2025[115] Employee and Operational Insights - Employee costs for the year amounted to RMB 34.2 million, slightly down from RMB 34.8 million in the previous year[88] - The total number of employees increased to 283 as of December 31, 2025, from 274 in 2024[88] - The group recorded a significant increase in employee benefits expenses, totaling RMB 32,723,000 compared to RMB 33,598,000 in the previous year[28] Investment and Future Projects - The company has made a capital commitment of RMB 44.6 million for investment projects as of December 31, 2025, compared to RMB 45.7 million in 2024[104] - The company has entered into a strategic cooperation agreement with Beijing Zhongqing Online Information Technology Co., Ltd. to execute the "Mountain River Universe Project," which aims to integrate cultural transmission and digital innovation[102] - The company is in the negotiation stage for a potential collaboration with Conflux Hong Kong Management Limited to develop a digital platform for cultural tourism assets[101]

Company Overview - Shandong Extreme Vision Technology Co., Ltd. reported preliminary financial results for the year ending December 31, 2025, as per the listing rules[3] - The company is listed under stock code 6636 and is registered in the People's Republic of China[2] Financial Information - The financial data for the year ending December 31, 2025, is available in the prospectus dated March 20, 2026, on the Hong Kong Stock Exchange website and the company's website[3] Governance Structure - The board of directors includes executive directors and independent non-executive directors, ensuring a diverse governance structure[4]

Financial Performance - Total revenue for the year ending December 31, 2025, is projected to be RMB 467,010,000[4] - Gross profit for the same period is expected to be RMB 105,691,000, representing a significant increase from previous figures[4] - The company reported a net loss of RMB 326,791,000 for the year ending December 31, 2025, compared to a net loss of RMB 361,130,000 in 2024, indicating a year-over-year improvement of approximately 9.5%[5] - Total revenue for 2025 was RMB 721,794,000, a decrease from RMB 740,727,000 in 2024, reflecting a decline of about 2.5%[6] - The company's operating loss was RMB 312,639,000 in 2025, compared to an operating loss of RMB 292,523,000 in 2024, representing an increase in losses of approximately 6.5%[5] - The company reported a pre-tax loss of RMB 294,730,000 for the year ending December 31, 2025, compared to a loss of RMB 351,045,000 in 2024, indicating a decrease in losses[39] - The total loss for the year was RMB 326.8 million, a reduction of RMB 34.3 million or 9.5% compared to the previous year[79] Revenue Breakdown - The group reported total revenue of RMB 88,533,000 for the year ending December 31, 2025, with contributions from men's apparel (RMB 70,216,000), industrial products (RMB 13,242,000), and energy storage batteries (RMB 5,075,000) [22] - Total revenue for the year ending December 31, 2024, is reported at RMB 467,010 thousand, with a breakdown of RMB 93,124 thousand from men's apparel, RMB 365,057 thousand from industrial products, and RMB 8,829 thousand from energy storage batteries[23] - The total revenue for 2025 was RMB 88,533 thousand, compared to RMB 467,010 thousand in 2024[34] - The industrial products segment generated RMB 13.2 million, accounting for 14.9% of total revenue, down 96.4% from RMB 365.1 million in 2024[68] - The men's apparel segment revenue decreased by approximately 24.6%, primarily due to lower sales prices and reduced market demand[70] - The energy storage battery segment reported revenue of RMB 5.1 million, representing 5.8% of total revenue, a decline of 42.0% from RMB 8.8 million in 2024[68] Expenses and Loss Provisions - Administrative expenses are estimated to be RMB 156,973,000 in 2024 and RMB 108,040,000 in 2025, indicating a cost reduction strategy[4] - The expected credit loss provisions are projected to decline from RMB 211,311,000 in 2024 to RMB 202,742,000 in 2025[4] - The expected credit loss provisions amounted to RMB 202,742,000, with industrial products contributing RMB 184,153,000 to this total [22] - The expected credit loss provision for trade receivables was RMB 196.5 million, a decrease from RMB 211.3 million in 2024[81] - The company’s total employee compensation costs, including salaries and benefits, decreased to RMB 25,553,000 in 2025 from RMB 35,010,000 in 2024, a decline of approximately 27.06%[36] Assets and Liabilities - The total assets decreased to RMB 393,612,000 in 2025 from RMB 486,563,000 in 2024, a decline of about 19.1%[6] - The company’s total liabilities were RMB 908,150,000 in 2025, down from RMB 922,802,000 in 2024, indicating a reduction of approximately 1.6%[6] - The company’s net asset value decreased to RMB 291,268,000 in 2025 from RMB 394,785,000 in 2024, representing a decline of about 26.2%[7] - The group has a net current liability of approximately RMB 328,182,000 as of December 31, 2025, indicating significant uncertainty regarding the group's ability to continue as a going concern[142] Strategic Initiatives - The company is focusing on expanding its market presence and enhancing product offerings in the energy storage sector[3] - Future outlook includes the development of new technologies aimed at improving operational efficiency and product performance[3] - The company plans to explore potential mergers and acquisitions to strengthen its market position and diversify its portfolio[3] - Strategic initiatives will be implemented to enhance customer engagement and drive revenue growth in the upcoming years[3] Share Issuance and Capital Raising - The company issued 524,431,000 new shares at a subscription price of HKD 0.55 per share, which was finalized on January 6, 2026[44] - The company raised approximately HKD 29.7 million (around RMB 27.5 million) from the subscription of 59,574,000 shares, which has been fully utilized for general working capital[125] - The net proceeds from the subscription of 42,000,000 shares amounted to approximately HKD 20.9 million (around RMB 19.1 million), also fully allocated for general working capital[127] - The subscription event is part of the company's strategy to raise capital for future growth initiatives[120] Market Conditions and Challenges - The industrial products division is facing significant challenges due to rising costs and a competitive environment, impacting profitability[52] - The ongoing Red Sea crisis is expected to ease significantly in the second half of 2025, improving the business outlook[52] - The economic growth in Saudi Arabia remains stable, but the country is facing fiscal deficits due to declining oil revenues in early 2024 and 2025[51] - The retail environment remains weak, leading distributors to place lower volume orders with varied product combinations, impacting economies of scale[58] Compliance and Governance - The board confirmed compliance with corporate governance standards, maintaining a structure of five executive directors, one non-executive director, and three independent non-executive directors[134] - The company has maintained the required public float as per listing rules as of the announcement date[132] - The audit committee, consisting of three independent non-executive directors, has reviewed the company's accounting principles and discussed relevant audits and financial reports[143]